Atlas Trials

Blood-sparing During Hip Prosthesis Surgery With Exacyl® in Patients Treated With Rivaroxaban

Clinical trial NCT02403596 · COMPLETED

Trial details

NCT number
NCT02403596
Sponsor
University Hospital, Brest
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Blood Loss After a Total Hip Replacement
Start date
2015-10-20
Primary completion
2017-08-29
Enrollment
231

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.